Brulíková, L.; Chasák, J.; Dak, M.; Šlachtová, V.; Cappoen, D.; Šebela, M.; Berka, K.; Bazgier, V.
New agents for the treatment of drug-resistant Mycobacterium tubercculosis
74. sjezd českých a slovenských chemických společností, September 4 – 7, 2022, Olomouc, přednáška .
Dak, M.; Šlachtová, V.; Šebela, M.; Bazgier, V.; Berka, K.; Smiejkowska, N.; Oorts, L.; Cappoen, D.; Brulíková, L.
Novel heterocyclic hydroxamates as inhibitors of the mycobacterial zinc metalloprotease Zmp1
56th Advances in Organic, Bioorganic and Pharmaceutical Chemistry, November 10 – 12, 2022, Špindlerův mlýn, poster .
Šlachtová, V.; Dak, M.; Šebela, M.; Cappoen, D.; Berka, K; Bazgier, V.; Brulíková, L.
Synthesis of novel potential mycobacterial Zmp1 inhibitors
56th International Conference on Medicinal Chemistry, July 7 – 9, 2021, virtual event, poster .
Chasák, J.; Dak, M.; Berka, K.; Bazgier, V.; Cappoen, D.; Brulíková, L.
Design and synthesis of new squaramides as mycobacterial ATP synthase inhibitors
55th Advances in Organic, Bioorganic and Pharmaceutical Chemistry, November 3 – 6, 2021, Špindlerův mlýn, poster .